We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0IV3 market cap is 1.97B. The company's latest EPS is USD -0.3391 and P/E is -7.55.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 460k | 253k | 1.39M | 596k | 237k |
| Operating Income | -72.7M | -76.91M | -114M | -138.55M | -193.94M |
| Net Income | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 165.52M | 270.73M | 226.03M | 190.58M | 394.08M |
| Total Liabilities | 30.36M | 59.78M | 99.62M | 110.58M | 146.13M |
| Total Equity | 135.16M | 210.95M | 126.42M | 80M | 247.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.9M | -66.65M | -95.56M | -127.38M | -167.74M |
| Investing | 27.4M | -105.32M | 71.95M | 62.07M | -180.32M |
| Financing | 19.57M | 168.35M | 48.56M | 87.26M | 362.02M |
| Market Cap | 1.97B |
| Price to Earnings Ratio | -7.55 |
| Price to Sales Ratio | 6.4k |
| Price to Cash Ratio | 19.86 |
| Price to Book Ratio | 5.61 |
| Dividend Yield | - |
| Shares Outstanding | 543.06M |
| Average Volume (1 week) | 7.85k |
| Average Volume (1 Month) | 6.6k |
| 52 Week Change | 0.00% |
| 52 Week High | 3.63 |
| 52 Week Low | 3.63 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Geron Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.geron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
